Nathan J. Shores

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

Thomas Boyer, Arun J. Sanyal, Florence Wong et al. · Gastroenterology · 2016 · 305 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling

Partha K. Chandra, Lili Bao, Kyoungsub Song et al. · American Journal Of Pathology · 2013 · 63 citations · Full text

Life Sciences, Cell Biology, Infectious Diseases +17

Epidemiology of Metastatic Hepatocellular Carcinoma, A Nationwide Perspective

Ali Abbas, Sabeen Medvedev, Nathan J. Shores et al. · Digestive Diseases and Sciences · 2014 · 48 citations

Medicine, Internal Medicine, Oncology +14

Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients

Nathan J. Shores, Ivana Maida, Vincent Soriano et al. · Journal of Hepatology · 2008 · 42 citations

Life Sciences, Infectious Diseases, Microbiology +12